SS18L1 and amyotrophic lateral sclerosis: Thus far, it has been shown that an ALS-associated CREST mutation leading to the deletion of the 9 C-terminal amino acids, Q388stop [4], abolishes its binding to CBP, suggesting that the missing amino acids act as an interface for interaction between the two proteins [6].